GE exits DIN-PACS bids to focus on private sectorGE Medical Systems early last month announced its withdrawal from the bidding process for the Defense Imaging Network-Picture Archiving and Communications Systems (DIN-PACS) project. The move
GE Medical Systems early last month announced its withdrawal from the bidding process for the Defense Imaging Network-Picture Archiving and Communications Systems (DIN-PACS) project. The move comes just weeks before bids are set to be awarded for the project, which some estimate to be worth $300 million to $1.25 billion.
GEMS officials say the company decided to exit the process after it was unable to meet two requirements in the project. The Milwaukee-based vendor participated throughout the benchmark testing and RFP responses, but was ultimately unsuccessful in its attempts to persuade the government to relax the requirements. Since developing those capabilities were not consistent with the company's plans for its commercial product line, GEMS made the difficult decision to withdraw, according to the firm.
In keeping with the confidential nature of the DIN-PACS bidding process, GEMS would not disclose the specific requirements it was unable to meet.
With GEMS now officially out of the running, the field has apparently narrowed to several consortia:
Although the government has not guaranteed PACS sales outside of the three projects it specified in the RFP, the real reward will come when Department of Defense hospitals look to acquire PACS technology. By one estimate, there are 123 hospitals in the network, many of which are looking to upgrade to digital image management (PNN 6/97).
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.